Current perspectives on CHEK2 mutations in breast cancer
Panagiotis Apostolou, Ioannis Papasotiriou Department of Molecular Medicine, Research Genetic Cancer Centre S.A. (R.G.C.C. S.A.), Florina, Greece Abstract: Checkpoint kinase 2 (CHEK2) is a serine/threonine kinase which is activated upon DNA damage and is implicated in pathways that govern D...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/917598b101cc43638d92488d7bcd6d41 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|